The association between cytokine gene polymorphisms and kidney allograft survival

Annals of Transplantation

Volumn 13, Issue 2, 2008, Pages 54-58

  Pawlik, Andrzej ^a   Domanski, Leszek ^a   Rozanski, Jacek ^a   Czerny, Bogusław ^a   Juzyszyn, Zygmunt ^a   Dutkiewicz, Grazyna ^a   Myslak, Marek ^a   Hałasa, Maciej ^a   Słojewski, Marcin ^a   Dabrowska Zamojcin, Ewa ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cytokines; Kidney allograft; Polymorphism

Indexed keywords

CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENOTYPE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MALE; COHORT ANALYSIS; GENETIC POLYMORPHISM; GENETICS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MIDDLE AGED; PROMOTER REGION; TIME;

COHORT STUDIES; FEMALE; GENOTYPE; GRAFT SURVIVAL; HUMANS; INTERLEUKINS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59649114636     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hutchinson IV, Turner D, Sankaran D et al:Cytokine genotypes in allograft rejection: guidelines for immunosuppression. Transplant Proc, 1998; 30: 3991-92
2. Hutchinson IV, Turner DM, Sankaran D et al: Influence of cytokine genotypes on allograft rejection. Transplant Proc, 1998; 30: 862-63
3. Sankaran D, Asderakis A, Ashraf S et al: Cytokine gene polymorphism predict acute graft rejection following renal transplantation. Kidney Int, 1999; 56: 281-88
4. Hutchinson IV, Pravica V, Sinnott P: Genetic regulation of cytokine synthesis: consequences for acute and chronic organ allograft rejection. Graft, 2000; 56: 281-84
5. Turner D, Grant SC, Yonan N et al: Cytokine gene polymorphism and heart transplant rejection. Transplantation, 1997; 64: 776-79
6. Miki C, McMaster P, Mayer AD et al: Factors predicting perioperative cytokine response in patients undergoing liver transplantation. Crit Care Med, 2000; 28: 351-54
7. Perrey C, Pravica V, Sinnott PJ: Genotyping for polymorphism in interferon-gamma, interleukin-10, transforming growth factor-beta1 and tumor necrosis factor-alpha genes: a technical report. Transpl Immunol, 1998; 6: 193-97
8. Cox ED, Hoffmann SC, DiMercurio BS et al: Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin- 6. Transplantation, 2001; 72: 720-26
9. Fishman D, Faulds G, Jeffery R et al: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 1998; 102: 1369-76
10. Cantagrel A, Navaux F, Loubet-Lescoulie P et al: Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum, 1999; 42: 1093-100
11. McLaughlin PJ, Aikawa A, Davies HM et al: Evaluation of sequential plasma and urinary tumour necrosis factor alpha levels in renal allograft recipients. Transplantation, 1991; 51: 1225-29
12. McLaughlin PJ, Aikawa A, Davies HM et al: Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients. Transplantation, 1991; 51: 1225-29
13. Heidenreich S, Lang D, Tepel M, Rahn KH: Monocyte activation for enhanced tumour necrosis factor-alpha and interleukin 6 production during chronic renal allograft rejection. Transpl Immunol, 1994; 2: 35-40
14. Heidenreich S, Lang D, Tepel M, Rahn KH: Monocyte activation for enhanced tumor necrosis factor-a and interleukin 6 production during chronic renal allograft rejection. Transplant Immunol, 1994; 2: 35-40
15. Wilson AG, Symons JA, McDowell TL et al: Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA, 1997; 94: 3195-99
16. Kroeger KM, Carville KS, Abraham LJ: The -308 tumour necrosis factor-alpha promoter polymorphism affects transcription. Mol Immunol, 1997; 34: 391-99
17. Xing Z, Gauldie J, Cox G et al: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest, 1998; 101: 311-20
18. Marshall SE, McLaren AJ, McKinney EF et al: Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation, 2001; 71: 469-76
19. Muller-Steinhardt M, Hartel C, Muller B et al: The interleukin-6 -174 promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int, 2002; 62: 1824-2
20. Pawlik A, Domanski L, Rozanski J et al: The cytokine gene polymorphisms in patients with chronic kidney graft rejection. Transpl Immunol, 2005; 14: 49-52